Several brokerages have updated their recommendations and price targets on shares of Merit Medical Systems (NASDAQ: MMSI) in the last few weeks:

  • 9/6/2017 – Merit Medical Systems had its “buy” rating reaffirmed by analysts at Canaccord Genuity. They now have a $45.00 price target on the stock.
  • 8/28/2017 – Merit Medical Systems was downgraded by analysts at UBS AG from a “strong-buy” rating to an “outperform” rating.
  • 8/28/2017 – Merit Medical Systems was downgraded by analysts at Citigroup Inc. from a “strong-buy” rating to an “outperform” rating. They now have a $44.00 price target on the stock. They noted that the move was a valuation call. They noted that the move was a valuation call.
  • 8/28/2017 – Merit Medical Systems had its “outperform” rating reaffirmed by analysts at Raymond James Financial, Inc.. They now have a $44.00 price target on the stock.
  • 7/28/2017 – Merit Medical Systems had its “buy” rating reaffirmed by analysts at Piper Jaffray Companies. They now have a $45.00 price target on the stock.
  • 7/27/2017 – Merit Medical Systems had its “buy” rating reaffirmed by analysts at Craig Hallum. They now have a $50.00 price target on the stock, up previously from $42.00.
  • 7/20/2017 – Merit Medical Systems is now covered by analysts at Bank of America Corporation. They set a “buy” rating and a $44.00 price target on the stock.

Merit Medical Systems, Inc. (NASDAQ:MMSI) traded up 0.36% on Monday, reaching $41.65. 277,772 shares of the company traded hands. The stock has a market capitalization of $2.09 billion, a price-to-earnings ratio of 59.33 and a beta of 1.25. The stock has a 50 day moving average of $41.11 and a 200-day moving average of $35.35. Merit Medical Systems, Inc. has a 1-year low of $20.70 and a 1-year high of $42.60.

Merit Medical Systems (NASDAQ:MMSI) last posted its earnings results on Wednesday, July 26th. The medical instruments supplier reported $0.36 EPS for the quarter, beating the Zacks’ consensus estimate of $0.29 by $0.07. Merit Medical Systems had a net margin of 4.87% and a return on equity of 9.78%. The company had revenue of $186.50 million for the quarter, compared to analysts’ expectations of $181.46 million. During the same quarter in the prior year, the company posted $0.26 earnings per share. Merit Medical Systems’s revenue for the quarter was up 23.4% compared to the same quarter last year. On average, equities analysts anticipate that Merit Medical Systems, Inc. will post $1.26 EPS for the current year.

In other Merit Medical Systems news, insider Richard W. Edelman sold 29,000 shares of the company’s stock in a transaction dated Tuesday, August 1st. The shares were sold at an average price of $41.19, for a total value of $1,194,510.00. Following the transaction, the insider now owns 35,000 shares of the company’s stock, valued at $1,441,650. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Kent W. Stanger sold 7,400 shares of the company’s stock in a transaction dated Tuesday, August 8th. The shares were sold at an average price of $42.22, for a total transaction of $312,428.00. The disclosure for this sale can be found here. Insiders sold 100,850 shares of company stock worth $4,042,077 in the last ninety days. 5.00% of the stock is currently owned by corporate insiders.

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Receive News & Stock Ratings for Merit Medical Systems Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems Inc and related stocks with our FREE daily email newsletter.